References
- 1. Moreno-Escobar M, Kataria S, Khan E, Subedi R, Tandon M, Peshwe K, et al - Acute transverse myelitis with Dysautonomia following SARSCoV-2 infection: A case report and review of literature. J Neuroimmunol. 2021Apr;353:577523.10.1016/j.jneuroim.2021.577523789568233640717
- 2. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Liu C, et al - Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020 Jul;87:18–22.10.1016/j.bbi.2020.03.031714668932240762
- 3. Verstrepen K, Baisier L, Cauwer H - Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg. 2020 July;1-10.10.1007/s13760-020-01412-4730343732562214
- 4. Lewis A, Frontera J, Placantonakis D, Lighter J, Galetta S, Balcer L, et al - Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci. 2021 Feb;421:117316.10.1016/j.jns.2021.117316783366933561753
- 5. Advani S, Zali A, Ommi D, Fatemi A, Khoshnoud J, Ashrafi F - Transverse myelitis in COVID-19 patients: Report of two cases. Research Square. 2020 Nov;10.21203.10.21203/rs.3.rs-107744/v1
- 6. Durrani M, Kucharski K, Fien S - Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report. Clin Pract Cases Emerg Med. 2020 Aug;4(3):344-348.10.5811/cpcem.2020.6.48462743424332926682
- 7. Espindola O, Brandao C, Gomes Y, Siqueira M, Soares C, Lima M, et al -Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int J Infect Dis. 2021 Jan;102:105-162.10.1016/j.ijid.2020.10.044759131933127503
- 8. Ali L, Khan A, Elalamy O, Canibano B, Al hatou M, Ghulam A, et al - A rare presentation of acute flaccid myelitis in covid-19 patient: a case report. PJNS. 2020 Jul; 15(3).
- 9. Abdelhady M, Elsotouhy A, Vattoth S, MBBCh, FRCR, DABR, et al - Acute flaccid myelitis in COVID-19. BJR Case Rep. 2020 Sep;6(3):20200098.10.1259/bjrcr.20200098746575132922857
- 10. Chakraborty U, Chandra A, Ray A, Biswas P - COVID-19-associated acute transverse myelitis: a rare entity. BMJ Case Reports CP 2020;13:e238668.10.1136/bcr-2020-238668744935332843475
- 11. Jarius S, Wildemann B - Devic’s disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874). Journal of the Neurological Sciences. 2015 Aug;358(1-2):419-421.
- 12. Wu Y, Zhong L, Geng J - Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models. Mult Scler Relat Disord. 2019 Jan;27:412-418.10.1016/j.msard.2018.12.00230530071
- 13. Kitley J, Leite M, George JS, Palace J - The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012 Mar;18(3):271-85.10.1177/135245851140616521669935
- 14. Lana-Peixoto A, Talim N - Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes. Biomedicines. 2019 Jun;7(2):42.10.3390/biomedicines7020042663122731212763
- 15. Asnafi S, Morris P, Sechi E, Pittock S, Weinshenker B, Palace J, et al - The frequency of longitudinally extensive transverse myelitis in MS: A population-based study. Mult Scler Relat Disord. 2020 Jan;37:101487.10.1016/j.msard.2019.10148731707235
- 16. Jobling K, Ledingham D, Guadagno J - Positive anti-MOG antibodies in a patient with Sjogren’s syndrome and transverse myelitis. Eur J Rheumatol. 2019 Apr;6(2):102-104.10.5152/eurjrheum.2018.18041646733230407164
- 17. Asundi A, Cervantes-Arslanian A, Lin N, Barbosa F - Infectious Myelitis. Semin Neurol. 2019 Aug;39(4):472–481.10.1055/s-0039-168892331533188
- 18. Mihai C, Jubelt B - Infectious Myelitis. Curr Neurol Neurosci Rep. 2012 Dec;12:633-641.10.1007/s11910-012-0306-322927022
- 19. Aguilo-Gordo D, Flores-Barragan M, Ferragut-Loret F, Guzman V -Acute myelitis and SARS-CoV-2 infection: A new etiology of myelitis? J Clin Nerosci. 2020 Oct;80:280-281.10.1016/j.jocn.2020.07.074752532433099361
- 20. West T, Hess C, Cree B - Acute Transverse Myelitis: Demyelinating, Inflammatory, and Infectious Myelopathies. Semin Neurol. 2012 Apr;32(2):97–113.10.1055/s-0032-132258622961185
- 21. Reindl M, Waters P - Myelin Oligodendrocytes glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019 Feb;15(2):89-102.10.1038/s41582-018-0112-x30559466
- 22. Peschl P, Bradl M, Hoftberger R, Reindl M - Myelin Oligodendrocyte Glycoprotein: Dechiphering a Target in Inflammatory Demyelinating Diseases. Front Immunol. 2017; 8: 529.10.3389/fimmu.2017.00529542059128533781
- 23. Rodriguez de Antonio L, Gonzalez-Suarez I, Perez M, Fernandez-Barriuso I - Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review. Mult Scler Relat Disord. 2021 Apr;49:102783.10.1016/j.msard.2021.102783782605833513521
- 24. Chow, CCN, Magnussen, J, Ip, J, Su, Y - Acute transverse myelitis in COVID-19 infection. BMJ Case Report CP. 2020;13:e236720.10.1136/bcr-2020-236720741884932784242
- 25. Novi, G, Rossi, T, Pedemonte, E, Saitta, L, Rolla C, Roccatagliata L, et al - Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020 Sep;7(5)e797.10.1212/NXI.0000000000000797728665032482781
- 26. Balasa R, Maier S, Bajko Z, Motataianu A, Crisan A, Balasa A -Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review. Acta Neurol Belg. 2015 Dec;115(4):635-42.10.1007/s13760-015-0479-z25944511
- 27. Roy D, Ghosh R, Dubey S, Ray K - Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2020 Aug;5:1-16.10.1017/cjn.2020.173753347732753076